Topcare lice killing creme rinse

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
Topcare lice killing creme rinse
Generic name
PERMETHRIN
Manufacturer
Topco Associates LLC
Product type
HUMAN OTC DRUG
SPL set ID
3b4146a6-7c54-4dd0-9388-1e38491d16f3
SPL ID
ed4f8790-6cfe-4de9-9193-401908cbdd4d
Version
2
Effective date
2020-01-31
Source export date
2026-09-28
Source partition
6
Source file
https://download.open.fda.gov/drug/label/drug-label-0006-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-09-28/e0861bcde1444ef952820955caafc6f3fd29783e5ade07a13d933aa3336b399f/drug-label-0006-of-0014.json.zip
Source manifest SHA-256
cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run
20260929T050834Z
Imported at
2026-09-29 05:40:41
Harmonized routes table
Harmonized routes
TOPICAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only Do not use • on children under 2 months of age • near the eyes • inside the nose, ear, mouth, or vagina • on lice in eyebrows or eyelashes. See your doctor. Ask a doctor before use if you are • allergic to ragweed. May cause breathing difficulty or an asthmatic episode. When using this product • keep eyes tightly closed and protect eyes with a washcloth or towel • if product gets into the eyes, immediately flush with large amounts of water • scalp itching or redness may occur Stop use and see a doctor if • breathing difficulty occurs • eye irritation occurs • skin or scalp irritation continues or infection occurs If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away. (1-800-222-1222)

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.